Identification and comparison of insulin pharmacokinetics injected with a new 4-mm needle vs 6- and 8-mm needles accounting for endogenous insulin and c-peptide secretion kinetics in non-diabetic adult males

Journal of Diabetes Investigation

Volumn 4, Issue 3, 2013, Pages 287-296

  Hirose, Takahisa ^a   Ogihara, Takeshi ^b   Tozaka, Shusaku ^c   Kanderian, Sami ^d   Watada, Hirotaka ^b  

^a TOHO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Nippon Becton Dickinson Company   (Japan)

^d BD Technologies   (United States)

Author keywords

Insulin; Needle length; Pharmacokinetics

Indexed keywords

C PEPTIDE; INSULIN; INSULIN LISPRO;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; JAPANESE; MALE; MAXIMUM PLASMA CONCENTRATION; NEEDLE; NEEDLE LENGTH; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SYRINGE NEEDLE; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER;

EID: 84877011160     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12035     Document Type: Article

References (26)

1. Frid A, Hirsch L, Gaspar R, et al. New injection recommendations for patients with diabetes. Diabetes Metab 2010; 36(Suppl 2): 3-18.
2. Asakura T, Seino H, Nunoi K, et al. Usability of a microtapered needle (TN3305) for insulin treatment in Japanese patients with diabetes mellitus: a comparative clinical study with a standard thin wall needle. Diabetes Technol Ther 2006; 8: 489-494.
3. Hanas R, Lytzen L, Ludvigsson J. Thinner needles do not influence injection pain, insulin leakage or bleeding in children and adolescents with type 1 diabetes. Pediatr Diabetes 2000; 1: 142-149.
4. Iwanaga M, Kamoi K. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6 mm and Micro Fine Plus 31-gauge 5 mm needles. Diabetes Technol Ther 2009; 11: 81-86.
5. McKay M, Compion G, Lytzen L. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes. Diabetes Technol Ther 2009; 11: 195-201.
6. Miyakoshi M, Kamoi K, Iwanaga M, et al. Comparison of patient's preference, pain perception, and usability between Micro Fine Plus 31-gauge needle and Microtapered NanoPass 33-gauge needle for insulin therapy. J Diabetes Sci Technol 2007; 1: 718-724.
7. Siegmund T, Blankenfeld H, Schumm-Draeger PM. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study. Diabetes Technol Ther 2009; 11: 523-528.
8. Gibney MA, Arce CH, Byron KJ, et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 2010; 26: 1519-1530.
9. Henriksen JE, Djurhuus MS, Vaag A, et al. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen. Diabetologia 1993; 36: 752-758.
10. Vaag A, Handberg A, Lauritzen M, et al. Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care 1990; 13: 74-76.
11. Vaag A, Pedersen KD, Lauritzen M, et al. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabet Med 1990; 7: 335-342.
12. Hirsch LJ, Gibney MA, Albanese J, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010; 26: 1531-1541.
13. Tominaga M, Makino H, Yoshino G, et al. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann Clin Biochem 2005; 42: 41-46.
14. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
15. Owens DR. Human Insulin: Clinical Pharmacological Studies in Normal Man. MTP Press, Boston, 1986.
16. Urae A, Maeda A, Bowsher RR, et al. Safety, pharmacokinetics and pharmacodynamics of fast-acting Insulin, LY275585, a Phase I study: comparison with regular human insulin (Humulin R). J Clin Ther Med 2000; 16: 1601-1611.
17. Van Cauter E, Mestrez F, Sturis J, et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 41: 368-377.
18. Watanabe RM, Steil GM, Bergman RN. Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion. Am J Physiol 1998; 274: E172-E183.
19. Watanabe RM, Bergman RN. Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. Diabetes 2000; 49: 373-382.
20. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098.
21. Savitzky A, Golay MJE. Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 1964; 36: 1627-1639.
22. Pharmaceutical and Food Safety Bureau. Guideline for Bioequivalence Studies of Generic Products. December, 2006.
23. World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations. Fortieth Report: Technical Report No. 937. 2006.
24. Kreugel G, Keers JC, Kerstens MN, et al. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diabetes Technol Ther 2011; 13: 737-741.
25. Hofman PL, Derraik JG, Pinto TE, et al. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care 2010; 33: 1940-1944.
26. Frid A, Linde B. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 1992; 9: 236-239.